Literature DB >> 16083319

Interleukin-1 may link helplessness-hopelessness with cancer progression: a proposed model.

Miriam Argaman1, Yori Gidron, Shmuel Ariad.   

Abstract

A model of the relations between psychological factors and cancer progression should include brain and systemic components and their link with critical cellular stages in cancer progression. We present a psychoneuroimmunological (PNI) model that links helplessness-hopelessness (HH) with cancer progression via interleukin-1beta (IL-1beta). IL-1beta was elevated in the brain following exposure to inescapable shock, and HH was minimized by antagonizing cerebral IL-1beta. Elevated cerebral IL-1beta increased cancer metastasis in animals. Inescapable shock was associated with systemic elevations of IL-1beta and peripheral IL-1beta was associated with escape from apoptosis, angiogenesis, and metastasis. Involvement of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis are discussed. Future studies need to identify the role of additional factors in this PNI pathway.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16083319     DOI: 10.1207/s15327558ijbm1203_5

Source DB:  PubMed          Journal:  Int J Behav Med        ISSN: 1070-5503


  29 in total

1.  Physiological correlates of learned helplessness in man.

Authors:  R J Gatchel; J D Proctor
Journal:  J Abnorm Psychol       Date:  1976-02

2.  Attributions, coping, and adjustment in children with cancer.

Authors:  N C Frank; R L Blount; R T Brown
Journal:  J Pediatr Psychol       Date:  1997-08

3.  Visualization and characterization of interleukin 1 receptors in brain.

Authors:  W L Farrar; P L Kilian; M R Ruff; J M Hill; C B Pert
Journal:  J Immunol       Date:  1987-07-15       Impact factor: 5.422

4.  Learned helplessness in humans: critique and reformulation.

Authors:  L Y Abramson; M E Seligman; J D Teasdale
Journal:  J Abnorm Psychol       Date:  1978-02

5.  Biomedical and psychosocial determinants of psychiatric morbidity among postoperative ambulatory breast cancer patients.

Authors:  T Akechi; T Okuyama; S Imoto; S Yamawaki; Y Uchitomi
Journal:  Breast Cancer Res Treat       Date:  2001-02       Impact factor: 4.872

6.  Hopelessness and risk of mortality and incidence of myocardial infarction and cancer.

Authors:  S A Everson; D E Goldberg; G A Kaplan; R D Cohen; E Pukkala; J Tuomilehto; J T Salonen
Journal:  Psychosom Med       Date:  1996 Mar-Apr       Impact factor: 4.312

7.  Adverse life events and breast cancer: case-control study.

Authors:  C C Chen; A S David; H Nunnerley; M Michell; J L Dawson; H Berry; J Dobbs; T Fahy
Journal:  BMJ       Date:  1995-12-09

8.  Comparison of the effects of intra-third ventricular administration of interleukin-1 or platelet activating factor on ACTH secretion and the sympathetic-adrenomedullary system in conscious rats.

Authors:  K Hashimoto; R Hirasawa; S Makino
Journal:  Acta Med Okayama       Date:  1993-02       Impact factor: 0.892

9.  Psychological coping mechanisms and survival time in metastatic breast cancer.

Authors:  L R Derogatis; M D Abeloff; N Melisaratos
Journal:  JAMA       Date:  1979-10-05       Impact factor: 56.272

10.  Bereavement and breast cancer.

Authors:  M Ewertz
Journal:  Br J Cancer       Date:  1986-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.